Home > News > 66/Lesion Size Index (LSI) – guided catheter ablation for atrial fibrillation: can tissue impedance drop help identifying desirable ablation settings and target indices?
Atrial Fibrillation
Read Time: 2 mins

66/Lesion Size Index (LSI) – guided catheter ablation for atrial fibrillation: can tissue impedance drop help identifying desirable ablation settings and target indices?

Published Online: September 27th 2010 European Journal of Arrhythmia & Electrophysiology. 2020;6(Suppl. 1):abstr66
Authors: M Leo (Presenting Author) - Oxford University Hospitals NHS Foundation Trust, Oxford; A Banerjee - University of Oxford, Oxford; A Briosa e Gala - Oxford University Hospitals NHS Foundation Trust, Oxford ; M Pope - Oxford University Hospitals NHS Foundation Trust, Oxford ; R J Hunter - Barts Heart Centre, London; T R Betts - Oxford University Hospitals NHS Foundation Trust, Oxford
Quick Links:
Article
Article Information
Article:

Background: Reliable creation of durable transmural lesions is the key for successful catheter ablation procedures. Tissue impedance drop during radiofrequency delivery has been traditionally used as an indicator of lesion formation and size. More recently, Lesion Size Index (LSI) has become available in clinical settings as marker of lesion formation. In animal studies LSI correlates with lesion size regardless of the power used, meaning that it is theoretically possible to achieve the same lesion size with different powers by modifying contact force and ablation time accordingly. However previous data also suggest that ablation lesions reach maturity after 20-30 sec of energy delivery and no further increase of lesion size is observed thereafter despite more prolonged ablation. We assessed the relationship between ablation parameters and tissue impedance drop, as surrogate marker of lesion size, to help establishing ideal ablation settings and target indices for atrial RF catheter ablation.

Methods: Consecutive patients undergoing their first left atrial catheter ablation for atrial fibrillation were enrolled. Point-by-point ablation was performed for all study ablations, using RF powers of 20, 30 or 40 W. Tissue impedance, contact force, RF power and LSI values were continuously recorded during ablation and sampled at 100 Hz. An STL filter was used to process the impedance data and remove noise. The mean contact force was calculated for every lesion. The effect of contact force and power on impedance drop was assessed. The variation of impedance drop over time and LSI were also investigated. The maximum percentage impedance drop for every interval was calculated relative to the starting impedance.

Results: A total of 3337 RF lesions, delivered in 44 patients, were included in the analysis. The maximum impedance drop achieved during RF delivery was progressively higher with use of higher RF powers (Figure 1).

No correlation was observed between contact force and maximum percentage impedance drop (Figure 2) in each power group. The incremental time analysis also showed progressively shorter ablation times required to reach the plateau of impedance drop with use of higher power (Figure 3). The LSI value required to reach maximum percentage impedance drop was progressively higher with higher power (Figure 4).

Conclusions: Regardless of the contact force used and despite more prolonged ablation durations, lower powers produce lower maximum percentage impedance drops. This could mean smaller lesion sizes achievable with lower powers. Higher LSI values could be needed with higher RF powers to reach the maximum achievable lesion size.

Article Information:

Further Resources

Share this Article
Related Content In Atrial Fibrillation
  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72